TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 68.35
-1.25 (-1.80%)
Apr 17, 2026, 1:25 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 27.77 billion as of April 16, 2026.
Market Cap
27.77B
Enterprise Value
27.23B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.35
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 27.77B, an increase of 197.74%. That is a compound annual growth rate of 282.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 27.77B | -39.11% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 45.43B |
| Shanghai Henlius Biotech | 45.14B |
| InnoCare Pharma | 32.25B |
| Genscript Biotech | 30.09B |
| Duality Biotherapeutics | 28.84B |
| Shanghai Bao Pharmaceuticals | 28.69B |
| Keymed Biosciences | 23.77B |
| Zai Lab | 20.72B |